🧠 A panel of 70+ leaders were asked about the usage of Gen AI in the planning process. ❎ Surprisingly, less than half are currently leveraging or intending to leverage generative AI for brand planning in 2024. 🔎 But why? Why aren’t senior teams embracing it more when it can do so much for them and their brands? Sean Rapson of EVERSANA CONSULTING and John Kenny, PhD of EVERSANA INTOUCH explain in "Bringing generative AI to the brand planning process: what marketers need to know". https://lnkd.in/ejnZCEvB #generativeAI #artificialintelligence #healthcaremarketing #pharma #brandmarketing #MedAdNews #brandplanning #strategy
Med Ad News’ Post
More Relevant Posts
-
🦁 "This year, I had the privilege of serving on the Cannes Lions Health 2024 Pharma Jury. As jurors, we prided ourselves on being the champions of creativity, seeking to award not only beautiful work, but work that pushes boundaries and propels our industry forward." 🚀 "Over two days of vigorous and inspiring deliberation, we formed lasting friendships and identified the following notable themes." Susan Perlbachs of EVERSANA INTOUCH shares her experience in the jury room at this year's Cannes Lions International Festival of Creativity. https://lnkd.in/e7BDtSYw #CannesLions2024 #healthcaremarketing #healthcareadvertising #pharma #innovation #pharmamarketing #diversityandinclusion
-
-
Biopharmaceutical manufacturers commercializing products in the United States rely on #marketing and #communications agency partners to inform the marketplace — patients, prescribers, payers, and everyone else who makes decisions about health care — on their product’s benefits and value. The agency partners they choose to work with can make or break a product’s success, but selecting the right collaborator isn’t always easy. Molly Brown of Omnicom Health Group and Megan Hall of Entrée Health explain in "Pitch perfect: RFP responses that don’t fall flat". https://lnkd.in/gBM2sS9h #healthcaremarketing #healthcareadvertising #pharmaadvertising #MedAdNews
-
-
To successfully launch rare disease drugs, with their small patient populations and high costs, pharma manufacturers need to get payers involved in discussions as soon as possible to ensure patient access. Curtis W., Kimberly Irish, PhD, and Zachary Guarino of Peregrine Market Access; Andrew Bast of Greater Than One; and Elizabeth Cobb of Mosaic Group | An IPG Health Company share their insights with Christiane Truelove in "Paying mind to the payers" in the latest issue of Med Ad News. https://lnkd.in/eR3DxF3S #healthcaremarketing #pharmamarketing #payers #marketresearch #artificialintelligence #raredisease #patientaccess #marketstrategy #MedAdNews
-
-
"Accelerated approval allows the FDA to rely on surrogate or intermediate clinical endpoints to approve therapies in a shorter time frame than would be possible with traditional endpoints, but it has come under scrutiny by some policymakers and researchers in recent years." Rachel Dolan of PhRMA and Tiernan Meyer of Avalere explain in their article featured in the latest issue of Med Ad News. https://lnkd.in/eGE2cjP2 #FDA #payers #acceleratedapproval #patientaccess #regulatorypathway
-
-
The most popular #socialmedia platform at the moment is #TikTok, but as the current administration cracks down on monopolies, anticompetitive practices, as well as #media companies under foreign ownership, the future of TikTok hangs in the balance. Ashley Haden of EVERSANA INTOUCH explains what a potential TikTok ban could mean to pharma advertisers. https://lnkd.in/eQ9cXxNT #healthcaremarketing #pharmamarketing
-
-
In 2024, the pharmaceutical industry finds itself confronting high complexity and competition — embracing innovative strategies to navigate these challenges is paramount to ensuring commercial success. Ryan Quigley of Inizio explains in "Navigating the opportunities and challenges in the pharmaceutical landscape of 2024". https://lnkd.in/eVJXG_Tr #artificialintelligence #healthoutcomes #marketaccess #omnichannel #patientengagement #pharmatrends #productlaunches #realworldevidence #MedAdNews
-
